Citadel Advisors - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 78 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$19,000
-58.7%
53,271
+74.0%
0.00%
Q1 2018$46,000
-31.3%
30,624
-34.8%
0.00%
Q4 2017$67,000
-11.8%
46,961
+42.3%
0.00%
Q3 2017$76,000
+406.7%
33,000
+192.0%
0.00%
Q2 2017$15,000
-93.4%
11,300
-89.3%
0.00%
Q1 2017$227,000
-42.7%
106,037
+17.8%
0.00%
Q4 2016$396,000
-17.5%
90,044
-9.0%
0.00%
Q3 2016$480,000
+879.6%
98,989
+610.5%
0.00%
Q1 2016$49,00013,9330.00%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 289,664$434,0000.43%
SALZHAUER MICHAEL 220,153$330,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,644,583$2,467,0000.08%
Brown Advisory Securities, LLC 272,000$408,0000.08%
Par Capital Management 4,431,301$6,647,0000.07%
ISTHMUS PARTNERS, LLC 176,170$264,0000.07%
FRANKLIN STREET ADVISORS INC /NC 96,429$145,0000.02%
GSA CAPITAL PARTNERS LLP 262,544$394,0000.02%
Ballentine Partners, LLC 100,000$150,0000.01%
NWAM LLC 20,000$30,0000.01%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders